UNSPSC 51412501: Azaclorzine

This classification denotes a vasodilating agent with the molecular formula C22H24ClN3OS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7N4BHX8N3L, chemically known as 10h-phenothiazine, 2-chloro-10-(3-(hexahydropyrrolo(1,2-a)pyrazin-2(1h)-yl)-1-oxopropyl)- but generally known as azaclorzine, which bears US NIH Compound Identifier 39526. Azaclorzine most often comes in base and hydrochloride forms.

UNSPSC 51412501 Azaclorzine, a Commodity code, represents pharmaceutical supply contracts that state and local governments procure for emergency medical services, public health programs, and multi-state cooperative purchasing vehicles. The scope encompasses individual medications and multi-source generic pharmaceuticals supplied through established wholesaler networks to fire departments, health and human services agencies, and hospital systems. Recent solicitations show state and local buyers acquiring specific branded and generic medications in volume, with quality assurance, expiration-date management, supply-chain compliance, and FDA/DSCSA certification as standard requirements.

Activity under this code spans city fire departments, state health agencies, and multi-jurisdictional cooperative purchasing alliances. The City of Tampa's Purchasing Department solicited Advanced Life Support Medications (IFB 26P00188, due April 8, 2026) for Tampa Fire Rescue, requesting four specific injectable medications totaling approximately 3,530 units with a $40,000 estimated value and a Small Local Business Enterprise sheltered-market designation offering a 5 percent bid discount. The Texas Health and Human Services Commission issued a Request for Information (RFI HHS0017013, response deadline April 3, 2026) to gather vendor capabilities for direct-to-manufacturer prescription fulfillment outside traditional pharmacy benefit manager and wholesaler channels. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered through the Minnesota Department of Administration, posted an RFP (S1070000015802, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed across Minnesota, Oregon, and other participating jurisdictions through three authorized wholesalers, with pricing weighted at 75 percent and contract terms of two years with optional extensions. Recent activity clusters in Florida, Texas, and the upper Midwest, with municipal fire rescue systems, state Medicaid and pharmacy benefit programs, and multi-state cooperatives as the primary soliciting bodies.